Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach
Table 1
Therapeutic strategies for multiple sclerosis.
Immunomodulator agent
Therapeutic action
Aire protein
Modulates the expression of tissue-specific antigens [33, 34].
Interferon-
INF- inhibits proinflammatory cytokines (TNFα, IL-6, IL-, and IL-17) and T-cell proliferation and clinically reduces the annual rate of relapsing [64, 65].
CD28
Binds to B7.1 (CD80) and B7.2 (CD86). CD4(+)CD28null T cells+ have been found in peripheral blood of patients with MS. These cells produce high levels of IFN- and are less susceptible to regulatory mechanisms [44–46].
Inducible costimulator protein
Binds to B7H and modulates Th1/Th2 cytokine production [44–46].
CD40
CD40 is involved in the induction of IL-6 and subsequent IL-17 production [47].
Increases the expression of Foxp3 transcriptional factor in Treg cells [48].
Foxp3
Regulator gene in Treg cells and determines its role in the maintenance of homeostasis and self-tolerance [39].
CD39 and CD73
Potent molecules involved in regulating IL-17 toxicity suppression [28, 49].
T cells expressing phenotype
Provides a first line of defense against infections, through the secretion of IFN-. Clonally expanded T cells were found in acute MS brain lesions [4].
cells
Source of cytokine in innate immunity and exhibit a potential influence on adaptive immune responses. In models of EAE have both protective and pathogenic roles [4].
TGF-
It has suppressive effects on both T- and B-cell-related immunity. The selective suppressive effects of TGF- on proinflammatory cytokines such as IFN-y, TNF-, and LT support a potential role for drugs that upregulate TGF- in diseases with prominent Th1 immune response [58–62].
IL-17
Potent proinflammatory cytokine. IL-17 induces the activation of enzyme matrix metalloproteinase-3 and recruits neutrophils to the site of inflammation [63].
Paraoxonase
Enzyme able to hydrolyze preformed oxidized lipids. Exerts a protective role against oxidative damage of cells and lipoproteins [66].
Dietary polyunsaturated fatty acids
Decrease the serum levels of TNFα, IL-1, IL-6, and nitric oxide catabolites of patients [67].
Uric acid, -tocopherol, ascorbate, carotenoids, and glutathione